Cara Therapeutics | CARA - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
Acadia Pharmaceuticals 11.33 1.25 2026-06
Cara Therapeutics 0.49 27.28 2026-03
Chugai Pharma 24.32 4.56 2026-06
Cipla 35.82 12.26 2026-06
Clal Biotechnology 11.67 2.62 2022-12
Compugen 5.45 1.39 2026-03
CSL 16.16 9.59 2025-12
Grifols 11.2 1.08 2025-12
Halozyme Therapeutics 12.51 1.15 2026-06
J&J 29.43 4.9 2026-06
Neurocrine Biosciences 22.1 5.99 2026-06
Pacira 35.68 2.9 2026-06
Pfizer 11.48 2.16 2026-06
RedHill Biopharma 0.04 0.03 2025-06
Supernus Pharmaceuticals 65.37 21.16 2026-06
Vanda Pharmaceuticals 16.79 7.07 2023-06